Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, Baker-Smith CM, Barone Gibbs B, Beaton AZ, Boehme AK, et al. 2024 Heart Disease and Stroke statistics: a report of US and Global Data from the American Heart Association. Circulation. 2024;149(8):e347–913.
Akhabue E, Thiboutot J, Cheng JW, Vittorio TJ, Christodoulidis G, Grady KM, Lerakis S, Kosmas CE. New and emerging risk factors for coronary heart disease. Am J Med Sci. 2014;347(2):151–8.
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937–52.
Zeng L, Moser S, Mirza-Schreiber N, Lamina C, Coassin S, Nelson CP, Annilo T, Franzen O, Kleber ME, Mack S, et al. Cis-epistasis at the LPA locus and risk of cardiovascular diseases. Cardiovasc Res. 2022;118(4):1088–102.
Article PubMed CAS Google Scholar
Domingues-Montanari S, Subirana I, Tomas M, Marrugat J, Senti M. Association between ESR2 genetic variants and risk of myocardial infarction. Clin Chem. 2008;54(7):1183–9.
Article PubMed CAS Google Scholar
Aherrahrou R, Guo L, Nagraj VP, Aguhob A, Hinkle J, Chen L, Yuhl Soh J, Lue D, Alencar GF, Boltjes A, et al. Genetic regulation of atherosclerosis-relevant phenotypes in human vascular smooth muscle cells. Circ Res. 2020;127(12):1552–65.
Article PubMed PubMed Central CAS Google Scholar
Jung C, Gene GG, Tomas M, Plata C, Selent J, Pastor M, Fandos C, Senti M, Lucas G, Elosua R, Valverde MA. A gain-of-function SNP in TRPC4 cation channel protects against myocardial infarction. Cardiovasc Res. 2011;91(3):465–71.
Article PubMed CAS Google Scholar
Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y, Yi C, Lindahl T, Pan T, Yang YG, He C. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol. 2011;7(12):885–7.
Article PubMed PubMed Central CAS Google Scholar
Loos RJ, Bouchard C. FTO: the first gene contributing to common forms of human obesity. Obes Rev. 2008;9(3):246–50.
Article PubMed CAS Google Scholar
Dina C, Meyre D, Gallina S, Durand E, Korner A, Jacobson P, Carlsson LM, Kiess W, Vatin V, Lecoeur C, et al. Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet. 2007;39(6):724–6.
Article PubMed CAS Google Scholar
Fischer J, Koch L, Emmerling C, Vierkotten J, Peters T, Bruning JC, Ruther U. Inactivation of the Fto gene protects from obesity. Nature. 2009;458(7240):894–8.
Article PubMed CAS Google Scholar
Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, Erdos MR, Stringham HM, Chines PS, Jackson AU, et al. A genome-wide association study of type 2 diabetes in finns detects multiple susceptibility variants. Science. 2007;316(5829):1341–5.
Article PubMed PubMed Central CAS Google Scholar
Mo C, Yang M, Han X, Li J, Gao G, Tai H, Huang N, Xiao H. Fat mass and obesity-associated protein attenuates lipid accumulation in macrophage foam cells and alleviates atherosclerosis in apolipoprotein E-deficient mice. J Hypertens. 2017;35(4):810–21.
Article PubMed CAS Google Scholar
Mo W, Chen Z, Zhang X, Dai G, Ma D, Pan J, Zhang X, Wu G, Fan W. N6-Methyladenosine demethylase FTO (Fat Mass and obesity-Associated protein) as a Novel Mediator of Statin effects in Human endothelial cells. Arterioscler Thromb Vasc Biol. 2022;42(5):644–58.
Article PubMed CAS Google Scholar
Sun J, Wang M, Jia F, Song J, Ren J, Hu B. FTO stabilizes MIS12 to inhibit vascular smooth muscle cell senescence in atherosclerotic plaque. J Inflamm Res. 2024;17:1857–71.
Article PubMed PubMed Central Google Scholar
Gustavsson J, Mehlig K, Leander K, Lissner L, Bjorck L, Rosengren A, Nyberg F. FTO genotype, physical activity, and coronary heart disease risk in Swedish men and women. Circ Cardiovasc Genet. 2014;7(2):171–7.
Article PubMed CAS Google Scholar
Aijala M, Ronkainen J, Huusko T, Malo E, Savolainen ER, Savolainen MJ, Salonurmi T, Bloigu R, Kesaniemi YA, Ukkola O. The fat mass and obesity-associated (FTO) gene variant rs9939609 predicts long-term incidence of cardiovascular disease and related death independent of the traditional risk factors. Ann Med. 2015;47(8):655–63.
Article PubMed CAS Google Scholar
Shahid SU, Shabana, Rehman A, Hasnain S. Role of a common variant of Fat Mass and obesity associated (FTO) gene in obesity and coronary artery disease in subjects from Punjab, Pakistan: a case control study. Lipids Health Dis. 2016;15:29.
Article PubMed PubMed Central Google Scholar
Vausort M, Niedolistek M, Lumley AI, Okninska M, Paterek A, Maczewski M, Dong X, Jager C, Linster CL, Leszek P, Devaux Y. Regulation of N6-Methyladenosine after Myocardial Infarction. Cells. 2022;11(15).
Mathiyalagan P, Adamiak M, Mayourian J, Sassi Y, Liang Y, Agarwal N, Jha D, Zhang S, Kohlbrenner E, Chepurko E, et al. FTO-Dependent N(6)-Methyladenosine regulates cardiac function during remodeling and repair. Circulation. 2019;139(4):518–32.
Article PubMed PubMed Central CAS Google Scholar
Doney AS, Dannfald J, Kimber CH, Donnelly LA, Pearson E, Morris AD, Palmer CN. The FTO gene is associated with an atherogenic lipid profile and myocardial infarction in patients with type 2 diabetes: a Genetics of Diabetes Audit and Research Study in Tayside Scotland (Go-DARTS) study. Circ Cardiovasc Genet. 2009;2(3):255–9.
Article PubMed PubMed Central CAS Google Scholar
Knuuti J, Ballo H, Juarez-Orozco LE, Saraste A, Kolh P, Rutjes AWS, Juni P, Windecker S, Bax JJ, Wijns W. The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability. Eur Heart J. 2018;39(35):3322–30.
Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Executive Group on behalf of the Joint European Society of Cardiology /American College of Cardiology /American Heart Association /World Heart Federation Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018;138(20):e618–51.
Joint Committee for Guideline R. 2018 Chinese Guidelines for Prevention and Treatment of Hypertension-A report of the Revision Committee of Chinese Guidelines for Prevention and Treatment of Hypertension. J Geriatr Cardiol. 2019;16(3):182–241.
American Diabetes Association Professional Practice C. 2. Diagnosis and classification of diabetes: standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S20–42.
Joint committee for guideline r. 2016 Chinese guidelines for the management of dyslipidemia in adults. J Geriatr Cardiol. 2018;15(1):1–29.
Zhou YL, Wu WP, Cheng J, Liang LL, Cen JM, Chen C, Liu X, Xiong XD. CircFOXO3 rs12196996, a polymorphism at the gene flanking intron, is associated with circFOXO3 levels and the risk of coronary artery disease. Aging. 2020;12(13):13076–89.
Article PubMed PubMed Central CAS Google Scholar
Tang SS, Xu S, Cheng J, Cai MY, Chen L, Liang LL, Yang XL, Chen C, Liu XG, Xiong XD. Two tagSNPs rs352493 and rs3760908 within SIRT6 gene are Associated with the severity of coronary artery disease in a Chinese Han Population. Dis Markers. 2016;2016:1628041.
PubMed PubMed Central Google Scholar
Hinney A, Nguyen TT, Scherag A, Friedel S, Bronner G, Muller TD, Grallert H, Illig T, Wichmann HE, Rief W, et al. Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants. PLoS ONE. 2007;2(12):e1361.
Article PubMed PubMed Central Google Scholar
Chiang KM, Chang HC, Yang HC, Chen CH, Chen HH, Lee WJ, Pan WH. Genome-wide association study of morbid obesity in Han Chinese. BMC Genet. 2019;20(1):97.
Article PubMed PubMed Central CAS Google Scholar
Reddy A, Venkatesh K, Sahu S, Roy PS, Datta K, Pearlin, Reddy LVK, Moghal ETB, Mullick M, Rao GHR, Sen D. Intron-specific single nucleotide polymorphisms of Fat Mass and obesity- Associated Gene in obese and overweight individuals of the Indian Adult Population- A Pilot Study. Curr Diabetes Rev. 2019;16(1):84–94.
留言 (0)